Phospholipase Cγ1 negatively regulates growth hormone signalling by forming a ternary complex with Jak2 and protein tyrosine phosphatase-1B

Jang Hyun Choi, Hyeon Soo Kim, Sun Hee Kim, Yong Ryoul Yang, Yun Soo Bae, Jong Soo Chang, H. Moo Kwon, Sung Ho Ryu, Pann Ghill Suh

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Growth hormone binds to its membrane receptor (GHR), whereby it regulates many cellular functions, including proliferation, differentiation and chemotaxis. However, although the activation of growth hormone-mediated signalling is well understood, the precise mechanism responsible for its regulation has not been elucidated. Here, we demonstrate that phospholipase Cγ1 (PLCγ1) modulates the action of growth hormone-mediated signalling by interacting with tyrosine kinase Jak2 (janus kinase 2) in a growth hormone-dependent manner. In the absence of PLCγ1 (PLCγ1-/-), growth hormone-induced JAK2 and STAT5 phosphorylation significantly increased in mouse embryonic fibroblasts (MEFs). Furthermore, the re-expression of PLCγ1 reduced growth hormone-induced Jak2 activation. Growth hormone-induced Jak2 phosphorylation was enhanced by siRNA-specific knockdown of PLCγ1. Interestingly, PLCγ1 physically linked Jak2 and protein tyrosine phosphatase-1B (PTP-1B) by binding to both using different domains, and this process was implicated in the modulation of cytokine signalling through Jak2. In addition, in PLCγ1-/- MEFs, growth hormone-dependent c-Fos activation was upregulated and growth hormone-induced proliferation was potentiated. These results suggest that PLCγ1 has a key function in the regulation of growth hormone-mediated signalling by negatively regulating Jak2 activation.

Original languageEnglish
Pages (from-to)1389-1397
Number of pages9
JournalNature Cell Biology
Volume8
Issue number12
DOIs
Publication statusPublished - 2006 Dec 1
Externally publishedYes

Fingerprint

Non-Receptor Type 1 Protein Tyrosine Phosphatase
Janus Kinase 2
Growth Hormone
Chemical activation
Phosphorylation
Fibroblasts
phospholipase C1
2-tyrosine
Chemotaxis
Protein-Tyrosine Kinases
Small Interfering RNA

ASJC Scopus subject areas

  • Cell Biology

Cite this

Phospholipase Cγ1 negatively regulates growth hormone signalling by forming a ternary complex with Jak2 and protein tyrosine phosphatase-1B. / Choi, Jang Hyun; Kim, Hyeon Soo; Kim, Sun Hee; Yang, Yong Ryoul; Bae, Yun Soo; Chang, Jong Soo; Moo Kwon, H.; Ryu, Sung Ho; Suh, Pann Ghill.

In: Nature Cell Biology, Vol. 8, No. 12, 01.12.2006, p. 1389-1397.

Research output: Contribution to journalArticle

Choi, Jang Hyun ; Kim, Hyeon Soo ; Kim, Sun Hee ; Yang, Yong Ryoul ; Bae, Yun Soo ; Chang, Jong Soo ; Moo Kwon, H. ; Ryu, Sung Ho ; Suh, Pann Ghill. / Phospholipase Cγ1 negatively regulates growth hormone signalling by forming a ternary complex with Jak2 and protein tyrosine phosphatase-1B. In: Nature Cell Biology. 2006 ; Vol. 8, No. 12. pp. 1389-1397.
@article{f6ce1563d2924cb39a5fcfa92297abd2,
title = "Phospholipase Cγ1 negatively regulates growth hormone signalling by forming a ternary complex with Jak2 and protein tyrosine phosphatase-1B",
abstract = "Growth hormone binds to its membrane receptor (GHR), whereby it regulates many cellular functions, including proliferation, differentiation and chemotaxis. However, although the activation of growth hormone-mediated signalling is well understood, the precise mechanism responsible for its regulation has not been elucidated. Here, we demonstrate that phospholipase Cγ1 (PLCγ1) modulates the action of growth hormone-mediated signalling by interacting with tyrosine kinase Jak2 (janus kinase 2) in a growth hormone-dependent manner. In the absence of PLCγ1 (PLCγ1-/-), growth hormone-induced JAK2 and STAT5 phosphorylation significantly increased in mouse embryonic fibroblasts (MEFs). Furthermore, the re-expression of PLCγ1 reduced growth hormone-induced Jak2 activation. Growth hormone-induced Jak2 phosphorylation was enhanced by siRNA-specific knockdown of PLCγ1. Interestingly, PLCγ1 physically linked Jak2 and protein tyrosine phosphatase-1B (PTP-1B) by binding to both using different domains, and this process was implicated in the modulation of cytokine signalling through Jak2. In addition, in PLCγ1-/- MEFs, growth hormone-dependent c-Fos activation was upregulated and growth hormone-induced proliferation was potentiated. These results suggest that PLCγ1 has a key function in the regulation of growth hormone-mediated signalling by negatively regulating Jak2 activation.",
author = "Choi, {Jang Hyun} and Kim, {Hyeon Soo} and Kim, {Sun Hee} and Yang, {Yong Ryoul} and Bae, {Yun Soo} and Chang, {Jong Soo} and {Moo Kwon}, H. and Ryu, {Sung Ho} and Suh, {Pann Ghill}",
year = "2006",
month = "12",
day = "1",
doi = "10.1038/ncb1509",
language = "English",
volume = "8",
pages = "1389--1397",
journal = "The BMJ",
issn = "0730-6512",
publisher = "Kluwer Academic Publishers",
number = "12",

}

TY - JOUR

T1 - Phospholipase Cγ1 negatively regulates growth hormone signalling by forming a ternary complex with Jak2 and protein tyrosine phosphatase-1B

AU - Choi, Jang Hyun

AU - Kim, Hyeon Soo

AU - Kim, Sun Hee

AU - Yang, Yong Ryoul

AU - Bae, Yun Soo

AU - Chang, Jong Soo

AU - Moo Kwon, H.

AU - Ryu, Sung Ho

AU - Suh, Pann Ghill

PY - 2006/12/1

Y1 - 2006/12/1

N2 - Growth hormone binds to its membrane receptor (GHR), whereby it regulates many cellular functions, including proliferation, differentiation and chemotaxis. However, although the activation of growth hormone-mediated signalling is well understood, the precise mechanism responsible for its regulation has not been elucidated. Here, we demonstrate that phospholipase Cγ1 (PLCγ1) modulates the action of growth hormone-mediated signalling by interacting with tyrosine kinase Jak2 (janus kinase 2) in a growth hormone-dependent manner. In the absence of PLCγ1 (PLCγ1-/-), growth hormone-induced JAK2 and STAT5 phosphorylation significantly increased in mouse embryonic fibroblasts (MEFs). Furthermore, the re-expression of PLCγ1 reduced growth hormone-induced Jak2 activation. Growth hormone-induced Jak2 phosphorylation was enhanced by siRNA-specific knockdown of PLCγ1. Interestingly, PLCγ1 physically linked Jak2 and protein tyrosine phosphatase-1B (PTP-1B) by binding to both using different domains, and this process was implicated in the modulation of cytokine signalling through Jak2. In addition, in PLCγ1-/- MEFs, growth hormone-dependent c-Fos activation was upregulated and growth hormone-induced proliferation was potentiated. These results suggest that PLCγ1 has a key function in the regulation of growth hormone-mediated signalling by negatively regulating Jak2 activation.

AB - Growth hormone binds to its membrane receptor (GHR), whereby it regulates many cellular functions, including proliferation, differentiation and chemotaxis. However, although the activation of growth hormone-mediated signalling is well understood, the precise mechanism responsible for its regulation has not been elucidated. Here, we demonstrate that phospholipase Cγ1 (PLCγ1) modulates the action of growth hormone-mediated signalling by interacting with tyrosine kinase Jak2 (janus kinase 2) in a growth hormone-dependent manner. In the absence of PLCγ1 (PLCγ1-/-), growth hormone-induced JAK2 and STAT5 phosphorylation significantly increased in mouse embryonic fibroblasts (MEFs). Furthermore, the re-expression of PLCγ1 reduced growth hormone-induced Jak2 activation. Growth hormone-induced Jak2 phosphorylation was enhanced by siRNA-specific knockdown of PLCγ1. Interestingly, PLCγ1 physically linked Jak2 and protein tyrosine phosphatase-1B (PTP-1B) by binding to both using different domains, and this process was implicated in the modulation of cytokine signalling through Jak2. In addition, in PLCγ1-/- MEFs, growth hormone-dependent c-Fos activation was upregulated and growth hormone-induced proliferation was potentiated. These results suggest that PLCγ1 has a key function in the regulation of growth hormone-mediated signalling by negatively regulating Jak2 activation.

UR - http://www.scopus.com/inward/record.url?scp=33751536492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751536492&partnerID=8YFLogxK

U2 - 10.1038/ncb1509

DO - 10.1038/ncb1509

M3 - Article

C2 - 17128263

AN - SCOPUS:33751536492

VL - 8

SP - 1389

EP - 1397

JO - The BMJ

JF - The BMJ

SN - 0730-6512

IS - 12

ER -